TY - JOUR
T1 - Abdominal tissue concentrations and penetration of carboplatin in a HIPEC procedure - Assessment in a novel porcine model
AU - Petersen, Elisabeth K.
AU - Bue, Mats
AU - Harlev, Christina
AU - Jørgensen, Andrea R.
AU - Schmedes, Anne
AU - Hanberg, Pelle
AU - Petersen, Lone K.
AU - Stilling, Maiken
N1 - Publisher Copyright:
© 2022 Elisabeth K. Petersen et al., published by De Gruyter, Berlin/Boston.
PY - 2022/9
Y1 - 2022/9
N2 - Objectives: Peritoneal dissemination from intraabdominal cancers is associated with poor prognosis and rapid disease progression. Hyperthermic intraperitoneal chemotherapy (HIPEC) is an antineoplastic treatment, which has improved survival and recurrence-free survival, but little is known about the acquired chemotherapy concentrations in local tissues. The aim of this study was to assess concentrations of carboplatin during and after HIPEC treatment dynamically and simultaneously in various abdominal organ tissues by means of microdialysis in a novel porcine model. Methods: Eight pigs underwent imitation cytoreductive surgery followed by HIPEC (90 min) using a carboplatin dosage of 800 mg/m2. Microdialysis catheters were placed for sampling of drug concentrations in various solid tissues: peritoneum, liver, bladder wall, mesentery and in different depths of one mm and four mm in the hepatoduodenal ligament and rectum. During and after HIPEC, dialysates and blood samples were collected over 8 h. Results: No statistically significant differences in mean AUC0-last (range: 2,657-5,176 min·μg/mL), mean Cmax (range: 10.6-26.0 μg/mL) and mean Tmax (range: 105-206 min) were found between the compartments. In plasma there was a tendency towards lower measures. No difference between compartments was found for tissue penetration. At the last samples obtained (450 min) the mean carboplatin concentrations were 4.9-9.9 μg/mL across the investigated solid tissues. Conclusions: Equal carboplatin distribution in abdominal organ tissues, detectable concentrations for at least 6 h after HIPEC completion, and a carboplatin penetration depth of minimum four mm were found. The present study proposes a new HIPEC porcine model for future research.
AB - Objectives: Peritoneal dissemination from intraabdominal cancers is associated with poor prognosis and rapid disease progression. Hyperthermic intraperitoneal chemotherapy (HIPEC) is an antineoplastic treatment, which has improved survival and recurrence-free survival, but little is known about the acquired chemotherapy concentrations in local tissues. The aim of this study was to assess concentrations of carboplatin during and after HIPEC treatment dynamically and simultaneously in various abdominal organ tissues by means of microdialysis in a novel porcine model. Methods: Eight pigs underwent imitation cytoreductive surgery followed by HIPEC (90 min) using a carboplatin dosage of 800 mg/m2. Microdialysis catheters were placed for sampling of drug concentrations in various solid tissues: peritoneum, liver, bladder wall, mesentery and in different depths of one mm and four mm in the hepatoduodenal ligament and rectum. During and after HIPEC, dialysates and blood samples were collected over 8 h. Results: No statistically significant differences in mean AUC0-last (range: 2,657-5,176 min·μg/mL), mean Cmax (range: 10.6-26.0 μg/mL) and mean Tmax (range: 105-206 min) were found between the compartments. In plasma there was a tendency towards lower measures. No difference between compartments was found for tissue penetration. At the last samples obtained (450 min) the mean carboplatin concentrations were 4.9-9.9 μg/mL across the investigated solid tissues. Conclusions: Equal carboplatin distribution in abdominal organ tissues, detectable concentrations for at least 6 h after HIPEC completion, and a carboplatin penetration depth of minimum four mm were found. The present study proposes a new HIPEC porcine model for future research.
KW - carboplatin
KW - hyperthermic intraperitoneal chemotherapy
KW - microdialysis
KW - pharmacokinetics
UR - http://www.scopus.com/inward/record.url?scp=85138631955&partnerID=8YFLogxK
U2 - 10.1515/pp-2022-0110
DO - 10.1515/pp-2022-0110
M3 - Journal article
C2 - 36159212
AN - SCOPUS:85138631955
SN - 2364-7671
VL - 7
SP - 117
EP - 125
JO - Pleura and Peritoneum
JF - Pleura and Peritoneum
IS - 3
ER -